To evaluate the T cell infiltration in responding and resistant tumors, immunohistochemical analyzes for CD3, CD8, PD-L1, and TIGIT were performed on the paired tumor samples, and the percentage of positively stained cells were determined using the digital pathology software QuPath with automated identifiers for each marker (Fig. 6a, b). The gene discussed is CD274; the disease is neoplasm.